These lipid bodies are most prevalent in AD brain tissue with a slight but not significant increase in individuals with AD-APOE4/4 compared to those with AD-APOE3/3 (Fig. 2b and Extended Data Fig. 4a). This evidence concerns the gene APOE and Alzheimer disease.